About Us
Annovis
Executives and Advisors
SAB and Board
Our Science
Planned Studies
Completed Phase 2 Studies
Safety
Animal Studies
Neurodegeneration
About Neurodegeneration
Mechanisms of Action
Document Library
Investors
News Releases
Events
Filings
Corporate Governance
Contact Us
About Us
Annovis
Executives and Advisors
SAB and Board
Our Science
Planned Studies
Completed Phase 2 Studies
Safety
Animal Studies
Neurodegeneration
About Neurodegeneration
Mechanisms of Action
Document Library
Investors
News Releases
Events
Filings
Corporate Governance
Contact Us
Hamburger
Investors
Stock Info
News Releases
July 24, 2024
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
July 16, 2024
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
July 9, 2024
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
MORE NEWS RELEASES
Events & Presentations
Heading
Annovis Bio - Phase III PD Data
View Webcast
Heading
AD & PD Data Updates - July 2024
Filings
For Year:
Form Filter
All Years
2024
2023
2022
2021
2020
2019
2017
2016
2015
2013
2010
Filing Type:
Form Filter
All Forms
Annual Report
Proxies
Quarterly Reports
Insider Trading
8-K
Other
Keyword search:
Records per Page:
Form Filter
5
10
15
20
25
50
Filings
Description
Date Filed
Available Formats
8-K
Current report filing
Jul 02, 2024
Format
Format
Format
Format
Format
Format
Format
S-8
Securities Registration: Employee Benefit Plan
Jun 21, 2024
Format
Format
Format
Format
Format
Format
8-K
Current report filing
Jun 13, 2024
Format
Format
Format
Format
Format
Format
Format
8-K
Current report filing
Jun 11, 2024
Format
Format
Format
Format
Format
Format
Format
8-K
Current report filing
Jun 05, 2024
Format
Format
Format
Format
Format
Format
Format
8-K
Current report filing
May 21, 2024
Format
Format
Format
Format
Format
Format
Format
8-K
Current report filing
May 13, 2024
Format
Format
Format
Format
Format
Format
Format
10-Q
Quarterly Report
May 10, 2024
Format
Format
Format
Format
Format
Format
Format
Format
8-K
Current report filing
May 09, 2024
Format
Format
Format
Format
Format
Format
Format
DEFA14A
Additional Proxy Soliciting Materials (definitive)
May 06, 2024
Format
Format
Format
Format
Format
«
1
2
3
4
5
...
21
22
»
Corporate Governance
Corporate Governance Guidelines
Nominating and Governance Committee Charter
Audit Committee Charter
Compensation Committee Charter
Code of Conduct
E-mail Alerts
Alert Categories
US Press Releases
Financial Calendar
All SEC Filings
Email address
*
Recaptcha
Spam protection: Please accept and solve the Captcha if prompted.
Unsubscribe from Investor Relations email alerts
Back to Top